Gene · 25913
NIH grants1,830
NIH grants whose papers are about the gene, through NIH's grant-paper links.
801 to 820 of 1,830
Download this page as JSON| Grant | Title | POT1 papers | Newest fiscal year |
|---|---|---|---|
| R01HD092084 | Improving Fertility Preservation in Boys with Cancer | 1 | 2019 |
| R01HL066216 | Risk Factors for Venous Thromboembolism in the Community | 1 | 2019 |
| R01HL079118 | Roles of Mre11 in Lymphocyte Development and DNA Repair | 1 | 2019 |
| R01HL093093 | Integrated cellular, mouse and human research on a novel missense variant influencing adiposity in Samoans | 1 | 2019 |
| R01HL128173 | Multiscale Modeling of Myelodysplastic Syndromes | 1 | 2019 |
| R01HL131789 | Signaling mechanisms by which mitochondria regulates fibrosis in the lung | 1 | 2019 |
| R01HL132071 | Novel Spliceosomal Defects in Myelodysplastic Syndromes | 1 | 2019 |
| R01HL133221 | Epigenetics of Arteriosclerosis in African American Hypertensive Sibships | 1 | 2019 |
| R01NS029993 | Risk Factors for Stroke and Cognitive Decline in a Tri-Ethnic Region | 1 | 2019 |
| R01NS069719 | Next Generation gene discovery in neurogenetics | 1 | 2019 |
| R21CA219884 | Evaluation of an OCA2 enhancer variant as a modifier of the phenotype of BAP1-Tumor predisposition syndrome | 1 | 2019 |
| R21HD090371 | Comprehensive mapping of mouse testis cell types and spermatogenic stages by single-cell RNA sequencing | 1 | 2019 |
| R24AI049393 | Severe Chronic Neutropenia International Registry | 1 | 2019 |
| R25GM058903 | University of California, Santa Cruz IMSD Program | 1 | 2019 |
| R33ES025606 | ROS driven mitochondrial-telomere dysfunction during environmental stress | 1 | 2019 |
| R56AG016642 | Mechanism of the telomeric proliferation limit | 1 | 2019 |
| RF1AG051504 | Integrative translational discovery of vascular risk factors in aging and dementia | 1 | 2019 |
| RF1AG058066 | Protective Genetic Variants for Alzheimer Disease in the Amish | 1 | 2019 |
| T32DK007378 | Kidney Research Training Program | 1 | 2019 |
| T32GM007092 | NRSA in Genetics | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25913/grants?page=41